Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India ETF Nifty 100 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | Nippon India | Nippon India |
| NAV | ₹283.0673 | ₹29.1863 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 13.7 years | 5.4 years |
| Expense ratio | 0.5% | 0.2% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| Nippon India ETF Nifty 100 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 1 month | +11.58% | +10.82% |
| 3 months | +4.99% | +7.43% |
| 6 months | +8.95% | +14.54% |
| YTD | +0.43% | +25.40% |
| 1 year | +0.13% | +25.57% |
| 3 years (CAGR) | +11.15% | +22.02% |
| 5 years (CAGR) | +8.72% | +16.60% |
| 10 years (CAGR) | +12.84% | — |
| Since launch | +12.71% | +14.02% |
Risk
| Nippon India ETF Nifty 100 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Volatility | 15.7% | 15.0% |
| Downside volatility | 10.6% | 9.0% |
| Sharpe | 0.30 | 1.04 |
| Sortino | 0.44 | 1.72 |
| Calmar | 0.64 | 1.33 |
| Return / risk | 0.71 | 1.47 |
| Deepest fall | −38.09% | −20.98% |
| Days to recover | 231 | 136 |
| Below its high | −0.98% | −1.75% |
Against benchmark
| Nippon India ETF Nifty 100 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Alpha | −0.00% | +0.00% |
| Beta | 1.00 | 1.00 |
| R² | 100.0% | 100.0% |
| Up capture | 100.0% | 100.0% |
| Down capture | 100.0% | 100.0% |
| Tracking error | 0.0% | 0.0% |
| Information ratio | — | — |
| Treynor | 0.04 | 0.14 |
Consistency
| Nippon India ETF Nifty 100 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Best 1-year | +93.37% | +65.21% |
| Middle 1-year | +10.69% | +13.46% |
| Worst 1-year | −33.33% | −15.30% |
| 1-year periods with a loss | 18.6% | 25.8% |
| Middle 3-year | +12.95% | +20.51% |
| Positive months | 63.9% | 61.1% |
| Best day | +3.94% | +3.64% |
| Worst day | −6.52% | −4.03% |
| Worst 5% day | −1.44% | −1.62% |
| Positive days | 54.9% | 54.4% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| Nippon India ETF Nifty 100 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 5-year XIRR | +9.40% | +20.60% |
| 5-year value | ₹7,63,947 | ₹10,11,738 |
| 3-year XIRR | +6.38% | +19.58% |
| 1-year XIRR | +10.41% | +34.31% |
Holdings overlap i
| Nippon India ETF Nifty 100 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Nippon India ETF Nifty 100 | — | 4% |
| Nippon India Nifty Pharma ETF | 4% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India ETF Nifty 100 | Nippon India Nifty Pharma ETF |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 1.44% | 18.61% |
| Divi's Laboratories Limited | 0.95% | 12.28% |
| Dr. Reddy's Laboratories Limited | 0.63% | 8.15% |
| Cipla Limited | 0.59% | 7.67% |
| Torrent Pharmaceuticals Limited | 0.52% | 6.71% |
| Zydus Lifesciences Limited | 0.24% | 3.05% |
Sectors and company size
| Nippon India ETF Nifty 100 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Large companies | 97.9% | 45.3% |
| Mid companies | 2.0% | 47.1% |
| Small companies | — | 7.6% |
| Top 10 holdings | 43.4% | 78.6% |
| Largest sector | Banks 25% | Pharmaceuticals & Biotechnology 100% |